Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer

被引：0
|
作者：
Sung-chan Gwark
Han Shin Lee
Youngjoo Lee
Sae Byul Lee
Guiyun Sohn
Jisun Kim
Il Yong Chung
Beom Seok Ko
Hee Jeong Kim
Byung Ho Son
Jin-Hee Ahn
Kyung Hae Jung
Sung-Bae Kim
Hee Jin Lee
Gyung-Yub Gong
Sei Hyun Ahn
Jong Won Lee
机构：
[1] University of Ulsan College of Medicine,Department of Surgery
[2] Asan Medical Center,Department of Oncology
[3] University of Ulsan College of Medicine,Department of Pathology
[4] Asan Medical Center,undefined
[5] University of Ulsan College of Medicine,undefined
[6] Asan Medical Center,undefined
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2166 / 2174
页数：8
相关论文
共 50 条
  • [21] Estrogen and progesterone hormone receptor status in HER2 positive breast cancers
    Kubelka-Sabit, K.
    Filipovski, V.
    Karagjozov, M.
    Stojcevska-Capova, M.
    Jasar, D.
    VIRCHOWS ARCHIV, 2015, 467 : S65 - S65
  • [22] Immunotherapy for hormone receptor-positive HER2-negative breast cancer
    Cardoso, Fatima
    Hirshfield, Kim M.
    Kraynyak, Kimberly A.
    Tryfonidis, Konstantinos
    Bardia, Aditya
    NPJ BREAST CANCER, 2024, 10 (01)
  • [23] Advanced luminal breast cancer (hormone receptor-positive, HER2 negative): New therapeutic options in 2015
    Vanacker, Helene
    Bally, Olivia
    Kassem, Loay
    Tredan, Olivier
    Heudel, Pierre
    Bachelot, Thomas
    BULLETIN DU CANCER, 2015, 102 (06) : S47 - S52
  • [24] Stromal Tumor-Infiltrating Lymphocytes in Hormone Receptor-Positive/HER2 Negative Metastatic Breast Cancer
    Pabba, Anirudh
    Zels, Gitte
    De Schepper, Maxim
    Geukens, Tatjana
    Van Baelen, Karen
    Maetens, Marion
    Leduc, Sophia
    Nguyen, Ha-Linh
    Mahdami, Amena
    Van Cauwenberge, Josephine
    Borremans, Kristien
    Izci, Hava
    Hatse, Sigrid
    Neven, Patrick
    Wildiers, Hans
    Biganzoli, Elia
    van den Bogaert, Wouter
    Richard, Francois
    Floris, Giuseppe
    Desmedt, Christine
    MODERN PATHOLOGY, 2025, 38 (02)
  • [25] Protein-protein interaction of HER2 predicts the prognosis of hormone receptor-positive HER2-negative breast cancer
    Choi, Hee Jun
    Lee, Hong Won
    Kim, Sangmin
    Yoon, Tae-Young
    Kim, Hyunwoo
    Lee, Seul
    Nam, Seok Jin
    Kim, Seok Won
    Cho, Sooyoun
    Park, Yeon Hee
    Lee, Jeong Eon
    CANCER RESEARCH, 2020, 80 (04)
  • [26] Prognostic significance of estrogen receptor in hormone receptor-positive and HER2-positive breast cancer
    Hikichi, M.
    Ushimado, K.
    Ri, Y.
    Kobayashi, N.
    Utsumi, T.
    BREAST, 2017, 32 : S94 - S95
  • [27] The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
    Bielo, Luca Boscolo
    Trapani, Dario
    Nicolo, Eleonora
    Valenza, Carmine
    Guidi, Lorenzo
    Belli, Carmen
    Kotteas, Elias
    Marra, Antonio
    Prat, Aleix
    Fusco, Nicola
    Criscitiello, Carmen
    Burstein, Harold J.
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2024, 128
  • [28] HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer
    Christian F. Singer
    Daphne Gschwantler-Kaulich
    Anneliese Fink-Retter
    Georg Pfeiler
    Ingrid Walter
    Gernot Hudelist
    Samir Helmy
    Anne-Catherine Spiess
    Wolfgang Lamm
    Ernst Kubista
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 807 - 813
  • [29] Hormone receptor status might be a determinant for HER2 loss after HER2-targeted treatment in HER2 positive breast cancer patients
    Altundag, Kadri
    JOURNAL OF BUON, 2019, 24 (05): : 2206 - 2206
  • [30] HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer
    Singer, Christian F.
    Gschwantler-Kaulich, Daphne
    Fink-Retter, Anneliese
    Pfeiler, Georg
    Walter, Ingrid
    Hudelist, Gernot
    Helmy, Samir
    Spiess, Anne-Catherine
    Lamm, Wolfgang
    Kubista, Ernst
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (06) : 807 - 813
12345